These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36617736)

  • 1. Assessing barriers and facilitators to transition in sickle cell disease care prior to implementation of a formalized program.
    Sheppard S; Hellemann G; Lebensburger J; Kanter J
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30160. PubMed ID: 36617736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions.
    Calhoun C; Luo L; Baumann AA; Bauer A; Shen E; McKay V; Hooley C; James A; King AA
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):e872-e880. PubMed ID: 35731941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
    Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescents with sickle cell disease in a rural community: are they ready to transition to adulthood?
    Mennito S; Hletko P; Ebeling M; Amann LA; Roberts J
    South Med J; 2014 Sep; 107(9):578-82. PubMed ID: 25188623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care.
    Andemariam B; Owarish-Gross J; Grady J; Boruchov D; Thrall RS; Hagstrom JN
    Pediatr Blood Cancer; 2014 Apr; 61(4):697-701. PubMed ID: 24347402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity.
    Kayle M; Docherty SL; Sloane R; Tanabe P; Maslow G; Pan W; Shah N
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27463. PubMed ID: 30251318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease.
    Howell KE; Saulsberry-Abate AC; Mathias JG; Porter JS; Hodges JR; Ataga KI; Anderson S; Nolan V; Hankins JS
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29209. PubMed ID: 34286896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
    DeBaun MR; Jordan LC; King AA; Schatz J; Vichinsky E; Fox CK; McKinstry RC; Telfer P; Kraut MA; Daraz L; Kirkham FJ; Murad MH
    Blood Adv; 2020 Apr; 4(8):1554-1588. PubMed ID: 32298430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
    Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
    JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of an educational intervention to optimize self-management and transition readiness in young adults with sickle cell disease.
    Calhoun CL; Abel RA; Pham HA; Thompson S; King AA
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27722. PubMed ID: 30907500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research.
    Treadwell M; Telfair J; Gibson RW; Johnson S; Osunkwo I
    Am J Hematol; 2011 Jan; 86(1):116-20. PubMed ID: 21061308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric to Adult Transition in Sickle Cell Disease: Survey Results from Young Adult Patients.
    Travis K; Wood A; Yeh P; Allahabadi S; Chien LC; Curtis S; Hammond A; Kohn J; Ogugbuaja C; Rees M; Shumway J; Sheehan V
    Acta Haematol; 2020; 143(2):163-175. PubMed ID: 31307033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Medical Student Mentors to Improve Transition in Sickle Cell Disease.
    Viola AS; Drachtman R; Kaveney A; Sridharan A; Savage B; Delnevo CD; Coups EJ; Porter JS; Devine KA
    J Pediatr Psychol; 2021 Jul; 46(6):650-661. PubMed ID: 33779756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.